TearClear: TearClear Raises $22M in Series B Funding

TearClear, a Boston, MA-based ophthalmic pharmaceutical company, raised $22M in a Series B funding round. Backers included Visionary Ventures, Bluestem Capital and Flying L Partners, who collaborated with Falcon Vision, a platform formed by KKR to advance innovation in ophthalmology. The company intends to use the funds to advance multiple clinical programs in development, with [...] The post TearClear Raises $22M in Series B Funding appeared first on FinSMEs.